WILSON JAMES N 4

What Happened

• James N. Wilson, a director of Corcept Therapeutics, reported a gift (disposition code G) of 28,000 common shares on March 13, 2026. The transaction price is listed as $0.00, so there were no proceeds recorded from this transfer. The Form 4 was filed with the SEC on March 17, 2026.

Key Details

• Transaction date: 2026-03-13
• Filing date: 2026-03-17 (filed within the typical two-business-day Form 4 window)
• Transaction type: Gift (code G); 28,000 shares disposed at $0.00
• Shares owned after transaction: not specified in the filing
• Footnote: The filer states he has voting power over shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners and disclaims beneficial ownership of those shares except for any pecuniary interest (Footnote F1). The form was signed under a power of attorney on file with the SEC.

Context

• Gifts are transfers for personal or estate-planning reasons and do not necessarily signal the insider’s view of the company’s prospects. This filing records the transfer but does not indicate any cash proceeds or a market-directional trade.